Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.
about
Development of a bead immunoassay to measure Vi polysaccharide-specific serum IgG after vaccination with the Salmonella enterica serovar Typhi Vi polysaccharideVi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses.Salmonella enterica serovar typhimurium trxA mutants are protective against virulent challenge and induce less inflammation than the live-attenuated vaccine strain SL3261.Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India.Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugatesPhase I clinical trial of O-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccineAn Appraisal of the Clinical Features of Pediatric Enteric Fever: Systematic Review and Meta-analysis of the Age-Stratified Disease Occurrence.Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunizationAntigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogenPrevention and self-treatment of traveler's diarrhea.Stochastic simulation of endemic Salmonella enterica serovar Typhi: the importance of long lasting immunity and the carrier state.The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines.In vivo regulation of the Vi antigen in Salmonella and induction of immune responses with an in vivo-inducible promoterConstruction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25.Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.A Study on Longevity of Immune Response after Vaccination with Salmonella Typhi Vi Conjugate Vaccine (Pedatyph™) in ChildrenGlycoconjugate vaccine strategies for protection against invasive Salmonella infections.rIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium.Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned.Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese childrenTyphoid fever and genetic polymorphisms at the natural resistance-associated macrophage protein 1.A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi.O-Serotype Conversion in Salmonella Typhimurium Induces Protective Immune Responses against Invasive Non-Typhoidal Salmonella Infections.The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.Development of a synthetic Vi polysaccharide vaccine for typhoid fever.Barriers to typhoid fever vaccine access in endemic countriesDevelopment of a novel S. Typhi and Paratyphi A outer membrane vesicles based bivalent vaccine against enteric feverEstablishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG
P2860
Q28394220-135FC821-6258-4388-A690-A8D2445F7A54Q30448411-FFAAF890-71B3-41F1-9E84-12AD3CB7FA01Q33557755-1D595A53-7F80-4D85-893C-95D7DBE60BDAQ33601836-CBB6ECF9-66BC-49F5-9AD0-9F3B617D119AQ33613531-D24D8A3C-6386-4579-AFDE-0D9BA3C83782Q33666510-A1D60442-295A-48B1-A1E5-3B7CDB995446Q33696180-8F141DFD-1433-4FCE-97EA-99EFF9B9B5FCQ34005612-3B15ACA6-825D-4A5E-B719-F935539C6E3EQ34515039-B0B0F18D-8D4D-4C03-AB17-FF215301B815Q34974972-CACC12BD-0F7A-4B34-A24C-4103825FB315Q34989762-0664EC03-5E54-4C8B-A09D-4C67E4163DC1Q35066191-9467307B-2870-420D-B85B-A75A3019E0CFQ35075822-266DA89B-DE2C-4152-94CE-A05B0B0BBF22Q35106317-1E0B6098-4EB3-4D95-94B8-EF067CE13AABQ35272921-5E47C5F7-EC3E-41D7-91B0-D639EFA9A727Q35575993-97EE1B3C-73E8-4ACC-9976-AB69892B54C7Q35729793-875288FB-CF5F-4BCC-B3D2-00C081F188BDQ35792498-B6AF8FAE-BA11-40EA-B08D-D4B22C0FE6EBQ36184367-6F8E8283-57CB-490B-9B14-67AC354436B4Q36302839-24C8EA15-C82A-41E8-909E-BFF689391C00Q37130816-A41DADFC-E398-4377-A339-A3B738A89368Q37340441-FA1CB013-6B85-41DE-BA8B-D842110C2BAFQ37582928-B69154AB-812D-4403-B797-70EF2B7B1D3CQ38849881-0955DF0A-79B1-46F6-ACD1-650920E3285FQ40291567-2C6F918D-8C86-4517-AF04-0A5FDF6B7406Q47103827-3DB249C0-8B14-44EF-B66C-7722B85FC5F3Q47245287-EE7E9E92-60D6-4552-92A0-B4FEB66FC213Q49914721-A513D504-CF40-4F39-900E-1981FA70263EQ57941639-1747B5BC-819A-4C16-BD7F-DB6275DBFBA4Q58741155-B6CB95CA-1F66-483F-9DD3-FF057E89AB6AQ59134868-1FE5E334-B940-4A53-B601-7468D6AF20DD
P2860
Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Safety and immunogenicity of V ...... -year-old children in Vietnam.
@ast
Safety and immunogenicity of V ...... -year-old children in Vietnam.
@en
Safety and immunogenicity of V ...... -year-old children in Vietnam.
@nl
type
label
Safety and immunogenicity of V ...... -year-old children in Vietnam.
@ast
Safety and immunogenicity of V ...... -year-old children in Vietnam.
@en
Safety and immunogenicity of V ...... -year-old children in Vietnam.
@nl
prefLabel
Safety and immunogenicity of V ...... -year-old children in Vietnam.
@ast
Safety and immunogenicity of V ...... -year-old children in Vietnam.
@en
Safety and immunogenicity of V ...... -year-old children in Vietnam.
@nl
P2093
P2860
P1476
Safety and immunogenicity of V ...... 4-year-old children in Vietnam
@en
P2093
J B Robbins
R Schneerson
P2860
P304
P407
P577
1999-11-01T00:00:00Z